Average Co-Inventor Count = 5.27
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (22 from 3,681 patents)
2. Bristol-myers Squibb (1 from 36 patents)
23 patents:
1. 8557841 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
2. 8232291 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
3. 7977353 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
4. 7910601 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
5. 7816357 - Azabicyclic heterocycles as cannabinoid receptor modulators
6. 7799801 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
7. 7592354 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
8. 7589102 - Heterocyclic aromatic compounds useful as growth hormone secretagogues
9. 7384958 - Quinoline inhibitors of cGMP phosphodiesterase
10. 7378418 - Azabicyclic heterocycles as cannabinoid receptor modulators
11. 7378430 - Quinoline inhibitors of cGMP phosphodiesterase
12. 7317012 - Bicyclic heterocycles as cannabinoind-1 receptor modulators
13. 7173042 - Quinoline inhibitors of cGMP phosphodiesterase
14. 7166603 - Dihydropyrimidone inhibitors of calcium channel function
15. 7166596 - Heterocyclic aromatic compounds useful as growth hormone secretagogues